作者: Aaron D. Krabill , Hao Chen , Sajjad Hussain , Chao Feng , Ammara Abdullah
关键词: Ubiquitin C-Terminal Hydrolase 、 Oncogene 、 Hydrolase 、 Structural biology 、 Cancer 、 Chemistry 、 Cancer research 、 In vivo 、 Ubiquitin 、 Deubiquitinating enzyme
摘要: The deubiquitinase (DUB) ubiquitin C-terminal hydrolase L1 (UCHL1) is expressed primarily in the central nervous system under normal physiological conditions. However, UCHL1 overexpressed various aggressive forms of cancer with strong evidence supporting as an oncogene lung, glioma, and blood cancers. In particular, level expression these cancers correlates increased invasiveness metastatic behavior, well poor patient prognosis. Although considered potential a therapeutic target, there remains significant lack useful small-molecule probes to pharmacologically validate vivo targeting enzyme. Herein, we describe characterization new covalent cyanopyrrolidine-based inhibitory scaffold biochemical cellular studies better understand utility this inhibitor elucidating role biology.